Insider · CIK 0001357149
Richard John Wallace
Files at IMGN (ImmunoGen, Inc.). First filing -, latest -.
In brief
Richard John Wallace files SEC Form 4 as director at IMGN (ImmunoGen, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Richard John Wallace has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Common Stock | -10,000 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Restricted Stock Unitderivative | -13,090 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Deferred Share Unitderivative | -102,326 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,000 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,000 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -5,000 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,000 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -18,000 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -18,000 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -50,000 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -44,000 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -44,000 | - | - | 0 | Feb 12, 2024 |
| Feb 12, 2024 | IMGN ImmunoGen, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -19,597 | - | - | 0 | Feb 12, 2024 |
| Nov 7, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Common Stock | +10,000 | $14.70 | $147k | 10,000 | Nov 8, 2023 |
| Nov 7, 2023 | IMGN ImmunoGen, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -10,000 | $0.00 | $0 | 0 | Nov 8, 2023 |
Questions about Richard John Wallace
Answered from the filings on this page, as of the latest one.
Is Richard John Wallace buying or selling?
Richard John Wallace has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Richard John Wallace's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Richard John Wallace has 0.
Where does Richard John Wallace file Form 4?
Richard John Wallace has filed Form 4 at IMGN (ImmunoGen, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.